Metraipolis › archive › dc_bd672f6b6bfe
PAM50 Intrinsic Subtypes and Immunity Status in Prognosis of Triple-Negative Breast Cancer: A Retrospective Cohort Study — Europe PMC PMID:41463257
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41463257
- DOI
- 10.3390/cancers17244010
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:50:53.214Z
- SHA-256 of the archived text
457c5d944b2c755b744d7470c4db5dbd20b50df790f2bea6559ce031c63e068d- Stable URL of this page
https://metraipolis.com/documento/dc_bd672f6b6bfe
How to cite
PAM50 Intrinsic Subtypes and Immunity Status in Prognosis of Triple-Negative Breast Cancer: A Retrospective Cohort Study — Europe PMC PMID:41463257 — Europe PMC (en), https://europepmc.org/article/MED/41463257 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd672f6b6bfe (Metraipolis archive dc_bd672f6b6bfe, sha256 457c5d944b2c755b744d7470c4db5dbd20b50df790f2bea6559ce031c63e068d)
BibTeX
@misc{dcbd672f6b6bfe,
title = {PAM50 Intrinsic Subtypes and Immunity Status in Prognosis of Triple-Negative Breast Cancer: A Retrospective Cohort Study — Europe PMC PMID:41463257},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41463257},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd672f6b6bfe; sha256 457c5d944b2c755b744d7470c4db5dbd20b50df790f2bea6559ce031c63e068d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41463257. Agents can read the archived copy with the MCP tool read_document.